Abstract:Graphical and Lay Summary The application of the Design‐Build‐Test‐Learn (DBTL) framework in enhancing erythromycin production from Saccharopolyspora erythraea. Through systematic metabolic engineering, a genetically modified strain was developed, showing improved erythromycin synthesis by suppressing the sucC gene and enhancing NADPH availability. Transcriptomic and metabolomic analyses revealed significant metabolic alterations, particularly in central carbon, amino acid, energy, and co‐factor/vitamin metabolism pathways. Despite increased amino acid metabolism leading to nitrogen depletion and potential cellular autolysis during fermentation, refining the process through ammonium sulfate supplementation resulted in a remarkable 43.5% increase in erythromycin yield (1125.66 mg/L). This work highlights the efficacy of the DBTL methodology in optimizing antibiotic production and offers insights into addressing the global challenge of antibiotic resistance. Industrial production of bioactive compounds from actinobacteria, such as erythromycin and its derivatives, faces challenges in achieving optimal yields. To this end, the Design‐Build‐Test‐Learn (DBTL) framework, a systematic metabolic engineering approach, was employed to enhance erythromycin production in Saccharopolyspora erythraea (S. erythraea) E3 strain. A genetically modified strain, S. erythraea E3‐CymRP21‐dcas9‐sucC (S. erythraea CS), was developed by suppressing the sucC gene using an inducible promoter and dcas9 protein. The strain exhibited improved erythromycin synthesis, attributed to enhanced precursor synthesis and increased NADPH availability. Transcriptomic and metabolomic analyses revealed altered central carbon metabolism, amino acid metabolism, energy metabolism, and co‐factor/vitamin metabolism in CS. Augmented amino acid metabolism led to nitrogen depletion, potentially causing cellular autolysis during later fermentation stages. By refining the fermentation process through ammonium sulfate supplementation, erythromycin yield reached 1125.66 mg L−1, a 43.5% increase. The results demonstrate the power of the DBTL methodology in optimizing erythromycin production, shedding light on its potential for revolutionizing antibiotic manufacturing in response to the global challenge of antibiotic resistance.

Efficient Ilamycins Production Utilizing Enteromorpha Prolifera by Metabolically Engineered Streptomyces Atratus

Enhancing production of a 24-membered ring macrolide compound by a marine bacterium using response surface methodology

Modular metabolic engineering of Bacillus amyloliquefaciens for high-level production of green biosurfactant iturin A

Enhanced Production of L-Tryptophan with Glucose Feeding and Surfactant Addition and Related Metabolic Flux Redistribution in the Recombinant Escherichia Coli

Characterization of Streptomyces Sp. LS462 with High Productivity of Echinomycin, a Potent Antituberculosis and Synergistic Antifungal Antibiotic

Effective Utilization of Wastewater for Valuable Validamycin A Biosynthesis by Streptomyces Hygroscopicus K2509 in Plant-Scale Bioreactor

Ribosome engineering and fermentation optimization leads to overproduction of tiancimycin A, a new enediyne natural product from Streptomyces sp. CB03234

Combinatorial metabolic engineering of Streptomyces sp. CB03234-S for the enhanced production of anthraquinone-fused enediyne tiancimycins

A Green Route for High-Yield Production of Tetramethylpyrazine From Non-Food Raw Materials

Avilamycin production enhancement by mutagenesis and fermentation optimization in Streptomyces viridochromogenes

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Fermentation Optimization and Industrialization of Recombinant Saccharopolyspora Erythraea Strains for Improved Erythromycin A Production

Enhanced ε-Poly-L-Lysine Production in Streptomyces albulus through Multi-Omics-Guided Metabolic Engineering

Metabolic engineering of Aureobasidium melanogenum 9–1 for overproduction of liamocins by enhancing supply of acetyl-CoA and ATP

Efficiently manufacturing ectoine via metabolic engineering and protein engineering of L-2,4-diaminobutyrate transaminase

Semi-Synthesis of Marine-Derived Ilamycin F Derivatives and Their Antitubercular Activities

Enhanced iturin a production in a two-compartment biofilm reactor by Bacillus velezensis ND

Production and Identification of Inthomycin B Produced by a Deep-Sea Sediment-Derived Streptomyces sp. YB104 Based on Cultivation-Dependent Approach

Enhancing erythromycin production in Saccharopolyspora erythraea through rational engineering and fermentation refinement: A Design‐Build‐Test‐Learn approach

Coproduction of polymalic acid and liamocins from two waste by-products from the xylitol and gluconate industries by Aureobasidium pullulans

Production of bioactive tryptamine derivatives by co-culture of marine Streptomyces with Bacillus mycoides